Rion (6823) Fundamentals 2026 — P/E 12.5x, Revenue Analysis | SniperIQ
Rion (6823) is a JP-listed Healthcare company in Medical - Specialties with a market capitalization of ¥42.0B, trading at ¥3405.00 on the JPX. This SniperIQ fundamentals page covers Rion's valuation (P/E 12.5x, P/B 1.2x), profitability (net margin 11.7%), revenue (¥28.5B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Rion's market cap?
Rion (6823) has a market capitalization of approximately ¥42.0B, trading at ¥3405.00 on the JPX. Market cap moves with the live share price.
What is Rion's P/E ratio?
Rion's trailing twelve-month P/E ratio is 12.5x, with a price-to-book (P/B) of 1.2x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Rion?
Rion runs a net profit margin of 11.7%, a gross margin of 49.1%, and an operating margin of 15.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Rion generate?
Rion reported revenue of ¥28.5B for fiscal year 2025, with net income of ¥3.3B and earnings per share (EPS) of 271.43. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Rion pay a dividend?
Rion offers a trailing dividend yield of about 2.5%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Rion financially healthy?
Rion carries a debt-to-equity ratio of 0.00x and a current ratio of 5.43x, with a market beta of 0.64. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Rion a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Rion (6823) the key facts are: market cap ¥42.0B, P/E 12.5x, revenue ¥28.5B, 52-week range 2480-4160. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Rion's full fundamentals live
Get Rion's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.